Skip to main content Skip to navigation
Menu
800-789-7366

Find a Doctor or Practice Location

You can also search for providers and practices at Penn Medicine Lancaster General Health or Princeton Health.

within
I am searching for a
Reset Form
Sunita Nasta, MD

Sunita Nasta, MD Physician

Associate Professor of Clinical Medicine

Dr. Nasta is employed by Penn Medicine.

Request a Callback
4.8out of 5
249 Patient Satisfaction Ratings

About Dr. Sunita Nasta

Recognized by America's Top Doctors 2015 – 2017
Recognized in Philadelphia magazine's annual Top Docs issues for 2018 and 2019

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Overall Ratings

Clinical Specialties

Specialty:

  • Hematology
  • Medical Oncology

Programs & Centers:

Board Certification:

  • Hematology, 2002
  • Medical Oncology, 2001

Clinical Expertise:

  • Hodgkin Lymphoma
  • Lymphoma
  • Non-Hodgkin Lymphoma

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Amerihealth Caritas
  • Amerihealth Caritas Medicare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • eLAP Services
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Homestead Smart Health Plans
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Provider Partners Health Plan
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Veterans Choice Program

Education and Training

Medical School: Virginia Commonwealth University
Residency: Baylor College of Medicine/Texas Children's Hospital
Residency: Baylor College of Medicine - Ben Taub General Hospital
Fellowship: Baylor College of Medicine/Texas Children's Hospital
Fellowship: University of Texas - MD Anderson Cancer Center
Fellowship: University of Texas Hospitals

Memberships

American College of Physicians, National American Medical Association, National American Society of Clinical Oncology, National American Society of Hematology, National Leukemia and Lymphoma Society, National

Hospital Affiliation

Dr. Nasta is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.

Research

Description of Research Expertise:

Clinical trials in non-Hodgkin's lymphoma, phase I, II and III

Selected Publications:

Hivnor CM, Nguyen V, Rook AH, Junkins-Hopkins J, Gelfand JM, Nasta S, Frank I, Kim EM: CD8+ lymphoma in a patient with human immunodeficiency virus Archives of Dermatology 141 (10): 1321-2,2005.

Tsai DE. Aqui NA. Vogl DT. Bloom RD. Schuster SJ. Nasta SD. Wasik MA. : Successful treatment of T-cell post-transplant lymphoproliferative disorder with the retinoid analog bexarotene. American Journal of Transplantation. 5 (8): 2070-3,2005.

Vogl DT. Glatstein E. Carver JR. Schuster SJ. Stadtmauer EA. Luger S. Nasta SD. Porter DL. Elstrom R. Tsai DE. : Gemcitabine-induced pericardial effusion and tamponade after unblocked cardiac irradiation. Leukemia & Lymphoma 46 (9): 1313-20,2005.

Loren AW. Luger SM. Stadtmauer EA. Tsai DE. Schuster S. Nasta SD. Goldstein SC. Perl A. Orloff G. Oliver JC. Green J. Emerson SG. Porter DL.: Intensive graft-versus-host disease prophylaxis is required after unrelated-donor nonmyeloablative stem cell transplantation. Bone Marrow Transplantation 35 (9): 921-6,2005.

Tsai DE. Maillard I. Downs LH. Alavi A. Nasta SD. Glatstein E. Schuster SJ.: Use of iodine 131I-tositumomab radioimmunotherapy in a patient with Waldenstrom's macroglobulinemia. Leukemia & Lymphoma 45 (3): 591-5,2004.

Nasta SD, Hoff PM, GeorgeCM, Neubauer, M, Cohen SC, Abbruzzese JA, Winn R., Pazdur RM: “Phase II Study of MGI-114 Administered Intravenously for Five Days Every 28 Days to Patients with Metastatic Colorectal Cancer” AJCO 26 (2): 132-134,2003.

Nasta SD, Carrum G., Shahab I., Hanania N, Udden MM: “Regression of a Plasmablastic Lymphoma in a Patient with HIV on Highly Active Antiretroviral Therapy” Leuk Lymphoma 43 (2): 423-426,2002.

Cohen AD, Luger SM, Sickles C, Mangan PA, Porter DL, Schuster SJ, Tsai DE, Nasta S, Gewirtz AM, Stadtmauer EA: “ Gemtuzumab ozogamicin (Mylotarg) monotherapy for relapsed AML after hematopoietic stem cell transplant: efficacy and incidence of hepatic veno-occlusive disease" Bone Marrow Transplant 30 (1): 23-28,2002.

Dwivedy, S: “Hodgkin’s Disease: Clinical Management and Future Perspectives” Fellows Reporter 6 (3): 2001.

Dwivedy S, . Hoff P. M, Dumas P., . Lassere Y, . Aguayo A, . Hayakawa T, Abbruzzese J.L.: Safety and phamacokinetics (PK) of an antitumor/antiangiogenic agent, TAS-102: a phase I study for patients(pts) with solid tumors ASCO : 2001.

Academic Contact Info

Division of Hematology Oncology
Perelman Center for Advanced Medicine
12th Floor, South Pavilion
Office #12-159
3400 Civic Center Boulevard
Philadelphia, PA 19104
Phone: (215) 662-3933
Patient appointments: 800-789-7366 (PENN)

Related Links

Penn Cancer Services